ARCHIVES

Cooperative Group chairmen Cool, But High Priority Trials To Continue

This article is from The Cancer Letter archive.

Vol. 17 No. 03 | January 18, 1991

Download PDF Visit The Full Archive

Related Articles

ODAC Recommends Fludarabine Approval for Refractory CLL

September 21, 1990

NCCS Networker Volume 10 Issue 1, Spring 1996

April 13, 1996

Groups Warn Against Cuts In Research, Seek Funds For NCI

February 10, 1995

ET2 Meber discusses Grants Funding Issue, Says Problem Is Money

July 23, 1993

Adding Velcade Increased Overall Survival By 13.3 Months at Five-Year Analysis

December 30, 2011

NCI Comprehensive Center List Omits Georgetown/Howard, Adds Arizona

June 1, 1990